Statins cut cardiovascular events in diabetic patients

Diabetics should be considered for statin therapy, claim experts from the UK and Australia.

The finding backs the inclusion of cholesterol in the diabetes domain of the quality framework.

The recommendation follows a meta-analysis of 8,686 patients with diabetes and 71,370 without it who took part in 14 statin trials. During a follow-up of 4.3 years, 3,247 of the diabetes patients suffered vascular events.

However, for every mmol/l reduction in LDL cholesterol, diabetes patients had a 21 per cent reduction in major vascular events.

This reduction in risk was similar irrespective of history of vascular disease and age.

After five years of therapy, there were 42 fewer cases of vascular events per 1,000 diabetic patients prescribed statin therapy.

GPs can earn up to three points for measuring cholesterol levels in diabetic patients.

Lancet 2008; 371: 117-25, link to the paper at

Statins for diabetes
After five years of statin therapy there were 42 fewer cases of vascular events per 1,000 diabetic patients

Source: Lancet


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus